About Informuta
Informuta is a Healthcare company based in New Orleans (United States) founded in 2023 by Kalen Hall and Leo Williams. Its chief executive, as recorded, is Kalen Hall. Its Indian entity Ta Associates Advisory Private Limited reported revenue of ₹205 Cr. Informuta offers products and services including RESISENSE. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Bacterial. Its competitors include OpGen, Day Zero Diagnostics and Clear Labs; 3 of its 3 listed competitors have raised funding.
Company details
Provider of predictive diagnostics for drug-resistant infections. It uses machine learning to analyze bacterial DNA to accurately guide effective treatment for difficult infections and predict if infections will become drug-resistant.
- Headquarters New Orleans, United States
- Founders Kalen Hall, Leo Williams
- SectorsHealthcare
- Website informuta.com
- Social LinkedIn X Instagram
- Legal Name Informuta, Inc.
- Date of Incorporation 15 Dec, 2008
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹205 Cr
FY 2025 · +92% YoY
- Indian entity net profit₹25.37 Cr
FY 2025 · 12% margin
- Indian entity EBITDA₹35.32 Cr
FY 2025 · 17% margin
- Latest Funding Round$275K (USD), Grant
Sep 2024
- Investors
Associated legal entities of Informuta
Informuta operates through Ta Associates Advisory Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ta Associates Advisory Private Limited CIN U74900MH2008PTC188893 | Active | 15 Dec 2008 | Mumbai, Maharashtra | ₹205 Cr | 3 | View details |
Products & Services of Informuta
Informuta offers a comprehensive portfolio of products and services, including RESISENSE.
AI-based platform to predict drug resistance for better patient treatment
Funding Insights of Informuta
- Total Rounds 1
- Last Round Grant — $275,000
- First Round $275,000
(Sep 2024)
- Investors Count 1
All 1 funding rounds of Informuta with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $275,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Informuta
Informuta has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Informuta
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ta Associates Advisory Private Limited (Informuta)
Ta Associates Advisory Private Limited is the primary company behind Informuta. The board of Ta Associates Advisory Private Limited currently have 3 directors; the longest-serving is Melanie Rae Toomey, appointed in 2015. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Melanie Rae Toomey DIN 07103302 | Director | 02 Mar 2015 | 11 yrs 8 mo | Ta Associates Advisory Private Limited |
| Ravindranath Menon Kizhakkepat Bhaskaran DIN 02579565 | Director | 01 Feb 2021 | 5 yrs 9 mo | Ta Associates Advisory Private Limited |
| Jennifer Ami Barbetta DIN 10709061 | Director | 25 Jul 2024 | 2 yrs 3 mo | Ta Associates Advisory Private Limited |
People of Informuta
2 people are tracked at Informuta (2 in leadership).
| Name | Role | Group |
|---|---|---|
Kalen Hall | Co-Founder & CEO | Leadership |
Leo Williams | Co-Founder | Leadership |
Complete people profiles for Informuta
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Informuta
Figures of Ta Associates Advisory Private Limited, the primary company behind Informuta, for FY 2025. Revenue was ₹205 Cr (+92% year on year). Net profit was ₹25.37 Cr (12% margin). EBITDA was ₹35.32 Cr (17% margin). Revenue has grown at a compounded annual rate of +46% over three years and +34% over five years.
- ₹205 CrRevenue · FY 2025 · +92% YoY
- ₹25.37 CrNet profit · 12% margin
- ₹35.32 CrEBITDA · 17% margin
- ₹2.56 CrPaid-up capital
- +46%Revenue CAGR, 3 years
- +34%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ta Associates Advisory Private Limited are on its company page.
Detailed financial statements for Informuta
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Informuta
2 dated milestones of Informuta across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Informuta is founded.
- Funding First funding round of $275K.
Competitors of Informuta
Informuta has 3 listed competitors in our database, 3 of them funded. They include OpGen, Day Zero Diagnostics and Clear Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| clearlabs.com | 2014 | Menlo Park, United States | $171.09M | 55 | Food safety technologies are provided for pathogen identification. |
Detailed competitors of Informuta
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Informuta (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Informuta
Complete news archive for Informuta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Informuta
Informuta was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Informuta is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
Kalen Hall is the CEO of Informuta, as recorded in our data. They have also founded this company.
The primary company behind Informuta, Ta Associates Advisory Private Limited, reported revenue of ₹205 Cr for FY 2025, up 92% year on year.
Provider of predictive diagnostics for drug-resistant infections. It uses machine learning to analyze bacterial DNA to accurately guide effective treatment for difficult infections and predict if infections will become drug-resistant.
Informuta's top competitors include Clear Labs, Day Zero Diagnostics and OpGen.
Informuta offers RESISENSE.
Informuta has 1 investor. Key investors include National Science Foundation.
Informuta operates through Ta Associates Advisory Private Limited.
The legal entities of Informuta currently have 3 directors, including Melanie Rae Toomey, Ravindranath Menon Kizhakkepat Bhaskaran, Jennifer Ami Barbetta.